Symbol
SABS on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
5.17M shares
Security Ownership
9.99%

BVF PARTNERS L P/IL ownership in SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS)

2025-11-14 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.17M shares of SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS). This represents 9.99% percent ownership of the company.